Skip to content
healthcare.dev

Mitoxantrone

NDC 61703-343, Mitoxantrone, injection, solution, concentrate, from Hospira, Inc..

Product NDC
61703-343
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076871
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61703-343 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MITOXANTRONE HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
61703-343-18617030343181 VIAL, MULTI-DOSE in 1 CARTON (61703-343-18) / 10 mL in 1 VIAL, MULTI-DOSE
61703-343-65617030343651 VIAL, MULTI-DOSE in 1 CARTON (61703-343-65) / 12.5 mL in 1 VIAL, MULTI-DOSE
61703-343-66617030343661 VIAL, MULTI-DOSE in 1 CARTON (61703-343-66) / 15 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/accf9569-4b57-4e83-a7db-4e890a75d1ba
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=61703-343

Use it

Look up 61703-343 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61703-343 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61703-343. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.